PICoP Global
Are you interested in learning about our current study on developing personalized, immune-based therapy to trigger patients’ own immune responses against tumors?
Watch Dr. Peter Bauer, MD, Chief Scientific Officer at CENTOGENE, as he discusses ‘PICoP global’ – our recently launched two-year global study that may have a considerable impact on cancer immunotherapy and individualized treatment for patients via peptide-based immunization for Colon- and Pancreas-Carcinoma.
Webinar Content:
• Colon and pancreas cancer in the developing countries
• Cancer immune therapy
• Neoepitopes as targets for patient-specific immune therapy
• Molecular approaches to identify neoepitopes
Our Speaker
Prof. Peter Bauer, M.D.
Chief Medical and Genomic Officer, CENTOGENE
Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Medical and Genomic Officer, where […]
Load content from Youtube?
By agreeing to load this content i accept to have my information shared with content provider (and it's partners). More info in our Privacy Policy.
